To hear about similar clinical trials, please enter your email below
Trial Title:
The Development of Quantitative Ultrasound Imaging Software Platform
NCT ID:
NCT05836246
Condition:
Chronic Liver Disease
Thyroid Disease
Benign Breast Disease
Malignant Breast Neoplasm
Acute Myocardial Infarction
Conditions: Official terms:
Breast Neoplasms
Liver Diseases
Myocardial Infarction
Breast Diseases
Fibrocystic Breast Disease
Thyroid Diseases
Infarction
Study type:
Observational [Patient Registry]
Overall status:
Enrolling by invitation
Study design:
Time perspective:
Prospective
Summary:
The goal of this observational study is to compare the image differences between
conventional ultrasound and artificial intelligence-based ultrasound software in
conscious adults.
The main question it aims to answer is to evaluate the effectiveness by determining that
the new image analysis method is considered valid if it helps to identify more than 30%
of histological characteristics.
Participants will undergo the examination using the two methods mentioned earlier after
signing the consent form.
Criteria for eligibility:
Study pop:
A person who visits Seoul National University Bundang Hospital for medical treatment or
consultation.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- People with heart disease, thyroid disease, breast disease, and liver disease.
Exclusion Criteria:
- Someone who has received surgery on the target organ in question.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Seoul National University Bundang Hospital
Address:
City:
Seongnam
Zip:
13620
Country:
Korea, Republic of
Start date:
September 1, 2020
Completion date:
March 31, 2026
Lead sponsor:
Agency:
Seoul National University Bundang Hospital
Agency class:
Other
Source:
Seoul National University Bundang Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05836246
